Exacerbation
Exacerbation - Related Videos
04:03
Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
0 Views •
2024
This protocol presents a novel approach to alleviating the symptoms and improving the quality of life of patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) by employing moving cupping along meridians therapy to stimulate the first sideline of the bladder meridian.
12:21
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
0 Views •
Cited by 4 •
2022
This paper describes a novel mouse model for the transition of pneumococcus from an asymptomatic colonizer to a disease-causing pathogen during viral infection. This model can be readily adapted to study polymicrobial and host-pathogen interactions during the different phases of disease progression and across various hosts.
04:53
Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
0 Views •
2024
The present protocol describes the specific process and efficacy of the acupoint application combined with ear plaster therapy for sleep disorders in a patient with acute exacerbation of chronic obstructive pulmonary disease, including medical devices, selection of acupoints, operating methods, and posttreatment care.
04:34
Climate Change - Concepts
0 Views •
2019
The certainty of climate change remains a public controversy despite the consensus among approximately 97% of active climate researchers, who not only agree that the Earth’s climate is changing but also state that this change is intensified by human activity, predominantly carbon emissions 1. The disconnect between the public and the experts is partly due to poor understanding of the mechanisms involved in climate change as well as the differences among essential concepts such as weather and...
04:00
A Murine Model of Primed Mycobacterial Uveitis to Study Post-Infectious Uveitis
0 Views •
2025
This video demonstrates a method to generate a mouse model of primed mycobacterial uveitis (PMU) for studying post-infectious uveitis. Upon induction of PMU by intravitreal injection of heat-killed Mycobacterium tuberculosis in a mouse previously immunized with the same immunogen, the progression of chronic inflammation in the eye is analyzed using imaging and histopathological...
FAQs
An exacerbation can reflect intensification of immune and inflammatory activity, which increases tissue dysfunction and amplifies symptoms. The biological change is not limited to the initial trigger; heightened responses can affect organ function as inflammation becomes more pronounced. Examining these processes helps researchers connect symptom severity with underlying biological activity rather than treating every flare as an isolated clinical event.
Infection, allergens, environmental stressors, and changes in treatment can each contribute to worsening disease activity. These factors may act as triggers that stimulate stronger immune or inflammatory responses, although their effects depend on the biological condition being studied. Identifying such associations allows researchers to investigate why symptoms increase and to distinguish potential initiating factors from downstream consequences.
A transient flare and continuous progression can both produce worsening symptoms, but they imply different patterns of disease activity. Tracking whether severity later returns toward a previous level helps researchers interpret an episode as a temporary change or as part of sustained deterioration. This distinction supports more accurate disease monitoring and helps evaluate whether an intervention changes the underlying course.
Biomarkers can provide measurable evidence of biological activity associated with worsening disease. When examined alongside symptoms and organ function, they may help identify inflammatory changes, compare episodes, and distinguish a temporary flare from broader progression. Their value lies in linking observable clinical outcomes with underlying mechanisms, giving researchers additional measures for monitoring disease activity and assessing interventions.
A useful investigation begins by documenting changes in symptoms, disease activity, and organ function relative to a period of stability. Researchers then examine possible triggers, assess immune or inflammatory activity, and compare relevant biomarkers across time. Finally, they evaluate whether observed changes represent a transient flare or ongoing progression, creating a framework for testing monitoring strategies and interventions.
Treatment changes become important when disease activity worsens after a period of relative stability or when an intervention is being assessed. Researchers can compare symptom severity, biological markers, and organ function before and after the change to examine associated outcomes. This approach helps determine whether treatment adjustments coincide with reduced activity, persistent dysfunction, or further worsening.
Studies of exacerbations can show how intensified disease activity affects organ function and how those functional changes relate to symptoms. Repeated observations reveal whether episodes are isolated, recurring, or associated with sustained impairment. These findings support disease monitoring and treatment planning by connecting biological activity with clinically meaningful outcomes rather than relying on symptom descriptions alone.